We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
If you have a long-term mental health condition you may be considered disabled under the Equality Act 2010
The characteristics, diagnosis, management, surveillance and epidemiology of CJD.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Information for clinicians and patients.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
Guillain-Barré syndrome is a rare neurological condition which can occur following Zika virus infection.
Guidance for health professionals on diagnoses, prevention and treatment of meningococcal disease.
How to spot equine viral encephalomyelitis, what to do if you suspect it and how to prevent it spreading.
Report certain types of mental health conditions to DVLA if you're a lorry, bus or coach driver.
The epidemiology, symptoms, diagnosis and management of monkeypox virus infections.
Guidance for people who have been diagnosed with a mpox infection and who have been advised to self-isolate at home.
Guidance for commissioners and health professionals to make decisions about mental health services and interventions based on data and analysis.
How to spot Batrachochytrium salamandrivorans, what to do if you suspect it and measures to prevent its spread.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Report certain types of mental health conditions to DVLA if you're a car driver or motorcyclist.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).